Which is performing better right now, JNJ or PFE?

Over the past month JNJ is -4.4% and PFE is +7.7%, so PFE is ahead on that window. Year to date the figures are +23.5% for JNJ and +18.8% for PFE.

What are the key levels for JNJ and PFE?

JNJ: resistance $265.23, support $251.08; PFE: resistance $30.00, support $28.85. Levels come from recent swing zones and round numbers, recomputed daily.

When do JNJ and PFE report next?

JNJ: 2026-10-13. PFE: 2026-11-03. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.

What does the JNJ/PFE ratio mean?

It is simply JNJ's price divided by PFE's — 8.6396 today. When the ratio rises, JNJ is outperforming; when it falls, PFE is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.

JNJ vs PFE

Johnson & Johnson against Pfizer — live side-by-side technical comparison.

Prices as of 2026-10-16T20:00:02+00:00 UTC · updates daily

Who leads right now

JNJ leads 3 of the 5 windows we measure — over 1 month JNJ is -4.4% and PFE +7.7%; over year to date JNJ is +23.5% and PFE +18.8%. The JNJ/PFE price ratio stands at 8.6396, below its 50-day average of 9.4881, and below the 200-day average of 9.2002. A ratio above its own average means JNJ is gaining on PFE; on this reading the recent edge belongs to PFE.

Performance side by side

	JNJ	PFE
Price	$255.56	$29.58
1 day	+0.9%lead	+0.5%
5 days	-2.2%	+4.6%lead
1 month	-4.4%	+7.7%lead
6 months	+9.0%lead	+8.7%
Year to date	+23.5%lead	+18.8%
52-week position	74% of range	95% of range
52-week range	$184.66–$281.07	$23.62–$29.88
vs 50-day average	below $265.23	above $27.97
vs 200-day average	above $244.12	above $26.56
RSI (14)	36	61
Next earnings	2026-10-13	2026-11-03

Where each one stands

JNJ — Johnson & Johnson

JNJ trades at $255.56, below its 50-day average of $265.23, and above the 200-day at $244.12. It sits at 74% of its 52-week range ($184.66–$281.07); 14-day RSI is 36, in neutral territory; an average session moves it about 2.5%. For levels, the first level overhead is $265.23 (3.8% away) and the first support below is $251.08 (1.8% down). On the checklist the page runs for every asset, 2 of 6 checks read bullish — the lean is bearish.

PFE — Pfizer

PFE trades at $29.58, above its 50-day average of $27.97, and above the 200-day at $26.56. It sits at 95% of its 52-week range ($23.62–$29.88); 14-day RSI is 61, in neutral territory; an average session moves it about 1.9%. For levels, the first level overhead is $30.00 (1.4% away) and the first support below is $28.85 (2.5% down). On the checklist the page runs for every asset, 6 of 6 checks read bullish — the lean is bullish.

Which one moves harder

JNJ is the more volatile of the two — an average session moves it 2.5% against 1.9% for PFE, so an identical position size carries roughly 1.3× the daily risk.

What would change the picture

The comparison turns on those levels: JNJ clearing $265.23 or losing $251.08; PFE clearing $30.00 or losing $28.85. Until one of them gives way, the relative reading above stands.

Questions people ask about JNJ vs PFE

Which is performing better right now, JNJ or PFE?: Over the past month JNJ is -4.4% and PFE is +7.7%, so PFE is ahead on that window. Year to date the figures are +23.5% for JNJ and +18.8% for PFE.
Is JNJ or PFE more volatile?: JNJ is the more volatile of the two — an average session moves it 2.5% against 1.9% for PFE, so an identical position size carries roughly 1.3× the daily risk.
What are the key levels for JNJ and PFE?: JNJ: resistance $265.23, support $251.08; PFE: resistance $30.00, support $28.85. Levels come from recent swing zones and round numbers, recomputed daily.
When do JNJ and PFE report next?: JNJ: 2026-10-13. PFE: 2026-11-03. Earnings reset both the trend and the levels above, so a comparison made today is only good until the next report.
What does the JNJ/PFE ratio mean?: It is simply JNJ's price divided by PFE's — 8.6396 today. When the ratio rises, JNJ is outperforming; when it falls, PFE is. Comparing it to its own 50- and 200-day averages shows whether the current leadership is new or long-standing.